Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Verrienti

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 6, 2021
In silico drug repurposing in COVID-19: A network-based analysisPasquale Sibilio, Simone Bini, Giulia Fiscon, et al.
International Journal of Endocrinology|March 26, 2019
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma CellsMarilena Celano, Valentina Maggisano, Saverio Massimo Lepore, et al.
Cancers|July 18, 2020
Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the ThyroidValeria Pecce, Antonella Verrienti, Luana Abballe, et al.
Journal of Endocrinological Investigation|September 19, 2024
Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinomaAntonella Verrienti, Valeria Pecce, Giorgio Grani, et al.
The Journal of Clinical Endocrinology and Metabolism|May 18, 2016
Risk Stratification of Neck Lesions Detected Sonographically During the Follow-Up of Differentiated Thyroid CancerLivia Lamartina, Giorgio Grani, Marco Biffoni, et al.
Endocrine|February 27, 2014
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutationCinzia Puppin, Cosimo Durante, Marialuisa Sponziello, et al.
European Journal of Endocrinology|June 10, 2011
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomasCosimo Durante, Giovanni Tallini, Efisio Puxeddu, et al.
Endocrine|September 16, 2015
Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancersMariavittoria Dima, Valeria Pecce, Mauro Biffoni, et al.
Journal of the Endocrine Society|December 22, 2017
Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-UpFrancesca Rosignolo, Marialuisa Sponziello, Laura Giacomelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistanceSofia Trocchianesi, Agnese Po, Anna Citarella, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 6, 2021
In silico drug repurposing in COVID-19: A network-based analysisPasquale Sibilio, Simone Bini, Giulia Fiscon, et al.
International Journal of Endocrinology|March 26, 2019
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma CellsMarilena Celano, Valentina Maggisano, Saverio Massimo Lepore, et al.
Cancers|July 18, 2020
Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the ThyroidValeria Pecce, Antonella Verrienti, Luana Abballe, et al.
Journal of Endocrinological Investigation|September 19, 2024
Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinomaAntonella Verrienti, Valeria Pecce, Giorgio Grani, et al.
The Journal of Clinical Endocrinology and Metabolism|May 18, 2016
Risk Stratification of Neck Lesions Detected Sonographically During the Follow-Up of Differentiated Thyroid CancerLivia Lamartina, Giorgio Grani, Marco Biffoni, et al.
Endocrine|February 27, 2014
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutationCinzia Puppin, Cosimo Durante, Marialuisa Sponziello, et al.
European Journal of Endocrinology|June 10, 2011
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomasCosimo Durante, Giovanni Tallini, Efisio Puxeddu, et al.
Endocrine|September 16, 2015
Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancersMariavittoria Dima, Valeria Pecce, Mauro Biffoni, et al.
Journal of the Endocrine Society|December 22, 2017
Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-UpFrancesca Rosignolo, Marialuisa Sponziello, Laura Giacomelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistanceSofia Trocchianesi, Agnese Po, Anna Citarella, et al.
Pageof 6